// App-Quantinova.ai

: Analysis of Immunological and Clinical Response to Vaccination Against Sars-COV-2 in Patients with Chronic Myeloid Leukemia

Researchers

Presenter

  • Alejandro ZURDO Castronuño

Principal Investigators

  • Miriam Solera Sainero

  • Magdalena Corona

  • Monserrat Torres

  • Guiomar Casado-Fernandez

  • Fernando Ramos-García

  • Javier Garcia-Pérez

  • María Aranzazú Murciano-Antón

  • Maria Jesus Blanchard

  • Juan Marquet Palomanes

  • Fernando Martin Moro

  • Mayte Pérez-Olmeida

  • Javier Lopez Jimenez

  • Maria Teresa Coiras

  • Sara Rodriguez-Mora

  • Valentin Garcia-Gutierrez

Medical Centers

  • Hospital Universitario Ramon y Cajal, Madrid, Spain

  • Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain

  • Family Medicine, Centro de Salud Doctor Pedro Laín Entralgo, Alcorcón, Spain

  • Hematology and Hemotherapy service, HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL, MADRID, Spain

  • Instituto De Salud Carlos III, Majadahonda, ESP

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

  • Coronavirus disease

Biomarkers

  • Annexin V

  • Breakpoint Cluster Region

  • Caspase 3

  • Peripheral blood mononuclear cell

  • Deleted in colorectal cancer

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A